Affinity-Bead Assisted Mass Spectrometry (Affi-BAMS): A Multiplexed Microarray Platform for Targeted Proteomics
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Authors: Hamza, Ghaith M.; Bergo, Vladislav B.; Mamaev, Sergey; Wojchowski, Don M.; Toran, Paul; Worsfold, Camilla R.; Castaldi, M. Paola; Silva, Jeffrey C.
Abstract
The ability to quantitatively probe diverse panels of proteins and their post-translational modifications (PTMs) across multiple samples would aid a broad spectrum of biological, biochemical and pharmacological studies. We report a novel, microarray analytical technology that combines immuno-affinity capture with Matrix Assisted Laser Desorption Ionization Mass Spectrometry (MALDI MS), which is capable of supporting highly multiplexed, targeted proteomic assays. Termed "Affinity-Bead Assisted Mass Spectrometry" (Affi-BAMS), this LC-free technology enables development of highly specific and customizable assay panels for simultaneous profiling of multiple proteins and PTMs. While affinity beads have been used previously in combination with MS, the Affi-BAMS workflow uses enrichment on a single bead that contains one type of antibody, generally capturing a single analyte (protein or PTM) while having enough binding capacity to enable quantification within approximately 3 orders of magnitude. The multiplexing capability is achieved by combining Affi-BAMS beads with different protein specificities. To enable screening of bead-captured analytes by MS, we further developed a novel method of performing spatially localized elution of targets from individual beads arrayed on a microscope slide. The resulting arrays of micro spots contain highly concentrated analytes localized within 0.5 mm diameter spots that can be directly measured using MALDI MS. While both intact proteins and protein fragments can be monitored by Affi-BAMS, we initially focused on applying this technology for bottom-up proteomics to enable screening of hundreds of samples per day by combining the robust magnetic bead-based workflow with the high throughput nature of MALDI MS acquisition. To demonstrate the variety of applications and robustness of Affi-BAMS, several studies are presented that focus on the response of 4EBP1, RPS6, ERK1/ERK2, mTOR, Histone H3 and C-MET to stimuli including rapamycin, H2O2, EPO, SU11274, Staurosporine and Vorinostat.
Activation of mTOR/I-kappa B-alpha/NF-kappa B pathway contributes to LPS-induced hypotension and inflammation in rats
EUROPEAN JOURNAL OF PHARMACOLOGY
Authors: Temiz-Resitoglu, Meryem; Kucukkavruk, Sefika Pinar; Guden, Demet Sinem; Cecen, Pelin; Sari, Ayse Nihal; Tunctan, Bahar; Gorur, Aysegul; Tamer-Gumus, Lulufer; Buharalioglu, Cuneyt Kemal; Malik, Kafait U.; Sahan-Firat, Seyhan
Abstract
Mammalian target of rapamycin (mTOR), a serine/threonine kinase plays an important role in various pathophysiological processes including cancer, metabolic diseases, and inflammation. Although mTOR participates in Toll-like receptor 4 signalling in different cell types, the role of this enzyme in sepsis pathogenesis and its effects on hypotension and inflammation in endotoxemic rats remains unclear. In this study we investigated the effects of mTOR inhibition on lipopolysaccharide (LPS)-induced changes on expressions and/or activities of ribosomal protein S6 (rpS6), an mTOR substrate, nuclear factor-kappa B (NF-kappa B) p65, inhibitor kappa B (I kappa B)-alpha, inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2 with production of nitric oxide, peroxynitrite, prostacyclin, and tumor necrosis factor (TNF)-alpha and activity of myeloperoxidase (MPO), which results in hypotension and inflammation. Injection of LPS (10 mg/kg, i.p.) to male Wistar rats decreased blood pressure and increased heart rate that were associated with elevated nitrotyrosine, 6-keto-PGF(1a), and TNF-alpha levels and MPO activity, and increased expressions and/or activities of rpS6, NF-kappa B p65, iNOS, and COX -2 and decreased expression of I kappa B-alpha in renal, cardiac, and vascular tissues. LPS also increased serum and tissue nitrite levels. Rapamycin (1 mg/kg, i.p.) given one h after injection of LPS reversed these effects of LPS. These data suggest that the activation of mTOR/I kappa B-alpha/NF-kappa B pathway associated with vasodilator and proinflammatory mediator formation contributes to LPS-induced hypotension and inflammation.